Genetic Disorders, Genotyping Techniques and the Emerging Role of Tetra-ARMS-PCR as a Diagnostic Tool

Resonance ◽  
2021 ◽  
Vol 26 (9) ◽  
pp. 1229-1240
Author(s):  
Motiur Rahaman ◽  
Mandrita Mukherjee ◽  
Nishant Chakravorty
Keyword(s):  
Diagnostic Tool ◽  
Genetic Disorders ◽  
Arms Pcr

scholarly journals How reliable is procalcitonin as an inflammatory marker?1)

2012 ◽  
Vol 35 (6) ◽  
pp. ---
Author(s):  
Katharina Biller ◽  
Peter Fae ◽  
Reinhard Germann ◽  
Autar K. Walli ◽  
Peter Fraunberger
Keyword(s):  
Intensive Care ◽  
Diagnostic Tool ◽  
Plasma Levels ◽  
Bacterial Infections ◽  
Respiratory Tract Infections ◽  
Inflammatory Marker ◽  
Antibiotic Use ◽  
Intensive Care Patients ◽  
Tract Infections

Abstract The role of procalcitonin (PCT) plasma levels as a diagnostic tool for intensive care patients has been intensively investigated during the past years. In particular for recognition of bacterial infections, PCT levels have been shown to be superior to other clinical and biochemical markers. Furthermore, some very recent studies show that in patients with lower respiratory tract infections PCT guided antibiotic therapy reduces antibiotic use and thereby may also reduce duration of stay of patients in hospital and thus cut hospitalisation costs. However, various studies indicate that the value of PCT as a prognostic marker is limited because of false positive or negative values. Despite these limitations PCT plasma levels are currently measured in intensive care units. The present study summarises the possible clinical uses of this laboratory marker as a diagnostic tool for the assessment of critically ill patients.

Abstract WMP40: Cervical Internal Carotid Artery Tortuosity as a Marker of Non-Atherosclerotic Aging: Results From the Northern Manhattan Study (NOMAS)

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Farid Khasiyev ◽  
Tatjana Rundek ◽  
Chensy Marquez ◽  
Clinton B. Wright ◽  
Ralph Sacco ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Internal Carotid Artery ◽  
Internal Carotid ◽  
Genetic Disorders ◽  
Matrix Remodeling ◽  
Plaque Area ◽  
Blood Pressures ◽  
The Right ◽  
Cervical Internal Carotid Artery

Background: Cervical internal carotid artery (ICA) tortuosity has been associated with vascular risk and stroke as well as genetic disorders related to abnormal extracellular matrix remodeling. It is plausible that dystrophic or aberrant arterial remodeling may therefore relate to cervical ICA tortuosity. We hypothesized that cervical ICA tortuosity relates to carotid dilatation, but not to traditional ultrasound (US) markers of atherosclerosis. Methods: Subjects of the NOMAS with available time-of-flight MRA were included in our study. Cervical ICA tortuosity was defined as a bend in the distal cervical ICA of > 90° as seen on MRA. We excluded subjects with < 5 cm of the cervical ICA visualized. Distensibility was calculated as the percentage excursion of the right CCA diastolic diameter during systole, which was assessed by high-resolution B-mode US of the right common carotid artery (CCA). We used multivariable logistic regression analyses to estimate odds ratios for the association of cervical ICA tortuosity and Doppler measures of carotid wall aging. Results: We visualized cervical ICA tortuosity in 468 NOMAS participants (mean age 64±8 years, 70% women, 70% Hispanic). It was present in 23% of subjects. In unadjusted models, cervical ICA tortuosity was more common in women (OR 2.34, 95% CI 1.34-4.11), Hispanics (OR 1.85, 95%CI 1.06-3.25) and those with higher diastolic blood pressures (OR per mm Hg 1.04, 95%CI 1.01-1.06), and less common among smokers (OR 0.23, 95%CI 0.07-0.78). In models adjusted for demographic and vascular risks, right CCA tortuosity was associated with ipsilateral larger CCA DD (OR 1.42, 95%CI 1.02-1.96) and borderline associated with lower distensibility (OR 0.94, 95%CI 0.87-1.01, P=0.06) but not with ipsilateral ICA IMT (OR 0.26, 95%CI 0.14-4.77), number of plaques (OR 1.08, 95%CI 0.76-1.53), maximum plaque thickness (OR 0.96, 95%CI 0.73-1.27), or plaque area (1.00, 95%CI 0.97-1.05). Conclusions: Cervical ICA tortuosity associates with ipsilateral cervical ICA dilatation and lower distensibility, but not with traditional US markers of atherosclerosis. The association with diastolic blood pressure suggests a role of steady, rather than pulsatile, hemodynamics in aberrant cervical ICA remodeling.

Reaching Future Scientists, Consumers, & Citizens

2014 ◽  
Vol 76 (6) ◽  
pp. 379-383 ◽  
Author(s):  
Melissa A. Hicks ◽  
Rebecca J. Cline ◽  
Angela M. Trepanier
Keyword(s):  
Personalized Medicine ◽  
Genetic Basis ◽  
Genetic Disorders ◽  
Single Gene ◽  
Personal Health ◽  
Adult Onset ◽  
Biology Textbooks ◽  
Multifactorial Diseases ◽  
Single Gene Disorders

An understanding of how genomics information, including information about risk for common, multifactorial disease, can be used to promote personal health (personalized medicine) is becoming increasingly important for the American public. We undertook a quantitative content analysis of commonly used high school textbooks to assess how frequently the genetic basis of common multifactorial diseases was discussed compared with the “classic” chromosomal–single gene disorders historically used to teach the concepts of genetics and heredity. We also analyzed the types of conditions or traits that were discussed. We identified 3957 sentences across 11 textbooks that addressed multifactorial and “classic” genetic disorders. “Classic” gene disorders were discussed relatively more frequently than multifactorial diseases, as was their genetic basis, even after we enriched the sample to include five adult-onset conditions common in the general population. Discussions of the genetic or hereditary components of multifactorial diseases were limited, as were discussions of the environmental components of these conditions. Adult-onset multifactorial diseases are far more common in the population than chromosomal or single-gene disorders; many are potentially preventable or modifiable. As such, they are targets for personalized medical approaches. The limited discussion in biology textbooks of the genetic basis of multifactorial conditions and the role of environment in modifying genetic risk may limit the public’s understanding and use of personalized medicine.

The role of hydrogen bonding in tuning CEST contrast efficiency: A comparative study of intra and inter molecular hydrogen bonding

2022 ◽  
Author(s):  
Shalini Pandey ◽  
Subhayan Chakraborty ◽  
Rimilmandrita Ghosh ◽  
Divya Radhakrishnan ◽  
Saravanan Peruncheralathan ◽  
...  
Keyword(s):  
Hydrogen Bonding ◽  
Comparative Study ◽  
Contrast Agents ◽  
Diagnostic Tool ◽  
Molecular Hydrogen

The effectiveness of MRI as a diagnostic tool have increased tremendously after the discovery of contrast agents (CA). Most of the clinically approved CAs at present are relaxation based and...

ROLE OF GENETIC POLYMORPHISMS ASSOCIATED WITH THROMBOPHILIA, PROTHROMBOTIC STATE AND FOLATE CYCLE DISTURBANCES IN WOMEN WITH REPRODUCTIVE DISORDERS

2017 ◽  
Author(s):  
А. Киселева ◽  
Е. Бутина ◽  
Г. Зайцева ◽  
Е. Попонина ◽  
С. Игнатьев ◽  
...  
Keyword(s):  
Genetic Disorders ◽  
Folate Metabolism ◽  
Clear Understanding ◽  
Reproductive Disorders ◽  
Primary Infertility ◽  
Risk Alleles ◽  
Heterozygous Form ◽  
Folate Cycle ◽  
Pai 1

Введение. Причины осложнения беременности достаточно многообразны: хромосомные и генетические нарушения, эндокринопатии, анатомические, инфекционные, иммунные и тромбофилические факторы. До настоящего времени нет четкого представления об истинных составляющих нарушения гестационного процесса. Материалы и методы. Проведено исследование аллелей, ассоциированных с тромбофилией и протромботическими состояниями, у 629 женщин и генов фолатного обмена у 277 женщин с отягощенным акушерским анамнезом. Результаты. Проанализирован характер распределения «аллелей риска» у женщин с первичным бесплодием, осложненными родами, неразвивающимися беременностями и у женщин без отягощенного акушерского анамнеза. Представлены данные о частоте встречаемости генетических мутаций, ассоциированных с тромбофилией (F2, F5), протромботическими состояниями (F7, F13, FGB, ITGA-2, ITGB-3, PAI-1) и нарушениями фолатного обмена (MTFFR, MTR, MTRR) у женщин с репродуктивными расстройствами. Заключение. Обнаружены статистически значимые различия в частоте распределения гетерозиготной формы полиморфизма ITGB3 у женщин с первичным бесплодием и осложненными родами в сравнении с женщинами без репродуктивных неудач. Влияние других полиморфных генов, ассоциированных с тромбофилией, протромботическими состояниями и нарушениями фолатного обмена, на наступление, течение и исход беременности не подтверждено. Introduction. The causes of pregnancy complications are quite multiformous: chromosomal and genetic disorders, endocrinopathies, anatomical, infectious, immune and thrombophilic factors. Until now there is no clear understanding of true components of gestational disorders. Materials and methods. We studied alleles associated with thrombophilia and prothrombotic conditions (in 629 women) and folate metabolism genes (in 277 women) with burdened obstetrical anamnesis. Results. The distribution of «risk alleles» in women with primary infertility, complicated delivery, non-developing pregnancy and at women without aggravated obstetric history was analyzed. Data about incidence of genetic mutations associated with thrombophilia (F2, F5), prothrombotic states (F7, F13, FGB, ITGA-2, ITGB-3, PAI-1) and folate metabolism disturbances (MTFFR, MTR, MTRR) in women with reproductive disorders are presented. Conclusion. Statistically signifi cant diff erences in distribution rate of heterozygous form of ITGB3 polymorphism in women with primary infertility and complicated delivery in comparison with women without reproductive failures were found. Impact of other polymorphic genes associated with thrombophilia, prothrombotic states and disturbances of folate metabolism to onset, gestation course and outcome of pregnancy was not proved.

Small-bowel bacterial overgrowth

2010 ◽  
pp. 2330-2334
Author(s):  
Richard A. Schatz ◽  
Phillip P. Toskes
Keyword(s):  
Small Bowel ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case History ◽  
Diagnostic Tool ◽  
Bacterial Overgrowth ◽  
Breath Tests ◽  
Small Bowel Bacterial Overgrowth ◽  
History Of

Case History—A 78 yr old woman presenting with a five-year history of diarrhoea. Updates Pathogenesis—discussion of the possible role of proton pump inhibitors. Diagnosis—comparison of lactulose hydrogen, glucose hydrogen, and 14C D-xylose breath tests; preliminary studies of circulating CdtB antibodies as a diagnostic tool....

Chronic heart failure diagnosis: genetics

ESC CardioMed ◽  
2018 ◽  
pp. 1781-1787
Author(s):  
Perry Elliott
Keyword(s):  
Heart Failure ◽  
Genetic Disorders ◽  
Fluid Retention ◽  
Response To Therapy ◽  
The Body ◽  
Clinical Approach ◽  
Functional Abnormality ◽  
Artery Disease ◽  
Heart Failure Diagnosis

Heart failure refers to a state in which the cardiac output, no longer compensated by endogenous mechanisms, fails to meet the metabolic demands of the body. Clinically, it is defined by symptoms of breathlessness, fatigue, fluid retention, and a cardiac structural or functional abnormality. Most cases of heart failure are caused by coronary artery disease, hypertension, diabetes, and valvular heart disease, but the risk of heart failure also depends on genetic predisposition for the causative disorder as well as genetic variation that modulates the maladaptive pathophysiological response to pathophysiological stressors and the response to therapy. In a small, but almost certainly underdiagnosed proportion of cases, heart failure is caused by Mendelian genetic disorders of heart muscle (cardiomyopathies) that are mostly inherited as autosomal dominant traits characterized by locus and allelic heterogeneity and highly variable clinical expression. This chapter briefly reviews the clinical approach to the diagnosis of genetic disorders that cause heart failure and the role of genetic testing in everyday practice.

scholarly journals THE ROLE OF ULTRASOUND AS A DIAGNOSTIC TOOL FOR SARCOPENIA

2018 ◽  
pp. 1-4 ◽  
Author(s):  
H.J. Stringer ◽  
D. Wilson
Keyword(s):  
Diagnostic Tool ◽  
Diagnostic Tools ◽  
Population Demographics ◽  
Skeletal Mass ◽  
Routine Diagnosis ◽  
Progressive Loss ◽  
Consequent Reduction ◽  
Potential Case ◽  
The Uk

Sarcopenia is the progressive loss of skeletal mass and strength, particularly in older adults, with consequent reduction in function and independence. Changing population demographics, have resulted in increased prevalence of sarcopenia and this is associated with a considerable economic burden. Whilst simple, effective, non-intrusive management of this condition exists, no routine diagnosis takes place either in the UK or in many other countries, partly due to an absence of pragmatic clinical diagnostic tools to support the early identification of the syndrome. This position paper aims to provide a short overview proposing the potential case for developing ultrasound as a new and alternative diagnostic tool for identifying sarcopenia.

Sign in / Sign up

Export Citation Format

Share Document